Na+/K+-ATPase level and products of lipid peroxidation in live cells treated with therapeutic lithium for different periods in time (1, 7, and 28 days); studies of Jurkat and HEK293 cells

Regulation of Na+/K+-ATPase in bipolar disorder and lithium therapy has been investigated for more than 40 years. Contradictory results in this area may be caused by the difference between acute and long-term Li effects on cell metabolism and variance in responsiveness of different cell types. We compared the time-course of Li action focusing on Na+/K+-ATPase and lipid peroxidation in two widely different cell models-Jurkat and HEK293. Na+/K+-ATPase expression level was determined in cells cultivated in the absence or presence of 1 mM Li for different time spans (1, 7, and 28 days) using [3H] ouabain binding and immunoblot assay of α-subunit. In parallel samples, the formation of malondialdehyde (MDA) was quantified by HPLC, and 4-hydroxy-2-nonenal (4-HNE) protein adducts were determined by immunoblot. Cultivation of Jurkat cells in 1 mM Li medium resulted in downregulation of Na+/K+-ATPase (decrease of [3H] ouabain-biding sites and intensity of immunoblot signals) in all Li-groups. In HEK293 cells, the decrease of Na+/K+-ATPase was observed after the acute, 1-day exposure only. The long-term treatment with Li resulted in Na+/K+-ATPase upregulation. MDA and 4-HNE modified proteins were decreased in Jurkat cells in all Li-groups. On the other hand, in HEK293 cells, MDA concentration was decreased after the acute, 1-day Li exposure only; the long-term cultivations, for 7 or 28 days, resulted in a significant increase of lipid peroxidation products. The Li-induced decrease of lipid peroxidation products was associated with the decrease of Na+/K+-ATPase level and vice versa.

Medienart:

E-Artikel

Erscheinungsjahr:

2019

Erschienen:

2019

Enthalten in:

Zur Gesamtaufnahme - volume:392

Enthalten in:

Naunyn-Schmiedeberg's archives of pharmacology - 392(2019), 7 vom: 01. Juli, Seite 785-799

Sprache:

Englisch

Beteiligte Personen:

Vosahlikova, Miroslava [VerfasserIn]
Roubalova, Lenka [VerfasserIn]
Ujcikova, Hana [VerfasserIn]
Hlouskova, Martina [VerfasserIn]
Musil, Stanislav [VerfasserIn]
Alda, Martin [VerfasserIn]
Svoboda, Petr [VerfasserIn]

Links:

Volltext

Themen:

EC 7.2.2.13
HEK293 cells
Journal Article
Jurkat cells
Lipid Peroxides
Lipid peroxidation products
Lithium
Lithium Compounds
Na+/K+-ATPase
Research Support, Non-U.S. Gov't
Sodium-Potassium-Exchanging ATPase

Anmerkungen:

Date Completed 20.05.2020

Date Revised 16.07.2021

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1007/s00210-019-01631-4

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM294150641